SynthesisClinical pharmacokinetics2025

Integrated Two-Analyte Population Pharmacokinetics Model of Patritumab Deruxtecan (HER3-DXd) Monotherapy in Patients with Solid Tumors.

Yuan Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.